G-actin modified by plasma membrane interaction polymerizes only in the presence of filamentous myosin  by Grazi, Enrico et al.
Volume 112, number 1 FEBS LETTERS March 1980 
G-ACTIN MODIFIED BY PLASMA ~E~3RANE INTERA~ION POLYMERIZES ONLY IN 
THE PRESENCE OF F~LAMENTOUS MYOSIN 
Enrico GRAZX, Albert0 FERRI, Vincenzo LANZARA, Ermes MAGRI and Margherita ZACCARINI 
Istituto di Chimica Biologica dell’Universitci di Ferrara, Via Luigi Borsari 46, 44100 Ferrara, Italy 
Received 5 February 1980 
1. Introduction 
In non-muscle cells actin can occur in different 
forms depending on the immediate and local needs 
of the cell. This suggests the presence of regulatory 
mechanisms capable to allow an easy interconversion 
between polymerization states of actin ranging from 
functional microfilaments to oligomeric or even 
monomeric actin. 
We describe here a potential regulatory mechanism 
mediated by the interaction of G-actin with plasma 
membranes. After the interaction G-actin is modified 
insuch a way that it does not polymerize in the pres- 
ence of 2 mM MgCl, but only in the presence ‘of 
myosin with the formation of contractile units. 
2. Materials and methods 
Plasma membranes were prepared from rat liver 
[I]. Rabbit muscle ATP-G-actin (myokinase-free) 
was prepared as in [2]; myosin as in [3] and myosin 
subfragment-l as in [4]. 
The extinction coefficients (ET?) used for myosin 
and for the subfragment-l were 5.43 [5] and 8.0 [6], 
respectively. The extinction coefficient (E$$)) used 
for G-actin was 6.2 171. 
Molar concerltrations were calculated on the basis 
of mol. wt 5 10 000 for myosin and 115 000 for sub- 
fragment-l [S] and of 42 000 for G-actin [9]. 
To measure the phosphate organically bound to 
actin, the supernatant solution, obtained after sedi- 
mentation of the plasma membranes, was treated 
with 5% trichloroacetic acid. The protein precipitate 
was treated according to [lo] and Pi was determined 
asin [ll]. 
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The inhibitory activity on DNase I was related to 
the concentration of actin by means of standard 
curves obtained by plotting known concentrations of 
G-actin against the corresponding inhibitory activity 
on a constant amount of DNase 1. DNase I activity 
(beef pancreas DNase I from Sigma) was determined 
spectrophotometrically at 260 nm in a test system 
containing 25 mM Tris-HCl buffer (pH 7.5), 5 mM 
MgCl*, 2 mM CaCI, and Sigma DNase type I, 40 pg/ 
ml. Polymerization of G-actin, induced by the addi- 
tion of 2 mM MgC&, was measured with an Ostwald 
viscosimeter maintained at 23 f O.l”C. 
Activation of myosin by actin (5 MM as the 
monomer) was measured at 23°C and pH 7.0 in a test 
system containing: 2 mM ATP, 0.15 M KCl, 10 mM 
Tris-HCl buffer and myosin (0.25 mg/ml). 
3. Results and discussion 
We have reported [12] that the properties of both 
G-a&n and F-actin are modified by the interaction 
with liver plasma membranes. These modifications are 
illustrated in table 1, where a typical experiment is 
reported. 
As a result of the interaction with plasma mem- 
branes G-actin is phospho~lated, loses the ability to 
inhibit pancreatic DNase I and to polymerize in the 
presence of 2 mM MgClz or 0.1 M KCl. 
The modified G-actin, however, retains the property 
to activate myosin. This data, which escaped recogni- 
tion in [ 121, is quite surprising. It was expected that 
the modified G-actin, which is not polymerized by 
2 mM MgC12, would have not been able to activate 
myosin. It is in fact known that G-actin activates 
myosin much less than F-actin [ 131. A possible expfa- 
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Table 1 
Modification of G-a&n by liver plasma membranes 
___~. _----.- 
Sample Time of Organic Actin retaining Relative Myosin 
incubation phosphate DNase I inhibi- viscosity activation 
(h) &MI tory activity (JIM) (o/n) 
.-___.-.-_---- ._~ ~_. _~_ 
G-Actin 0 1.2 24 2.15 230 
3 1.2 22 2.10 230 
G-Actin + 0 4.0 24 2.10 230 
plasma membranes 3 23 2 1.07 230 
l.--- - --~____I--._---- ---- 
The incubation mixtures contained 24 &l G-actin, 0.1 mM ATP, 0.2 mM C&l,, 2 mM Tris--HCl 
buffer and plasma membranes (2 mg/ml); pH 7.8; temp. 30°C. At time zero and after 3 II incu- 
bation samples were taken and actin was recovered in the supernatant solution by sedimenta- 
tion of the membranes at 17 000 X g and 2°C. Organic phosphate, DNase I inhibiting activity, 
relative viscosity and activation of myosin by actin were determined as in section 2 
nation of our data was that myosin could induce the 
polymerization of the modified G-actin. To test this 
hypothesis actoniyosin threads were prepared 1141 
by mixing either lllt~dified or native G-actin with 
myosin filaments prepared as in [ 151. As shown in 
table 2 the actomyosin threads prepared with native 
G-actin and those prepared with modified G-actin 
contracted to the same extent in the presence of 
2 m&l ATP. 
This means, evidently, that, in the presence of 
filamentous myosin, fiiamentous actin has been 
formed from modified G-actin. Only filamentous 
myosin, however, induces the formation of fila- 
mentous actin from modified G-actin. This was shown 
by treating modified G-actin with myosin snbfrag- 
ment-1 at low ionic strength. While the addition of 
Table 2 
Contraction, by the action of ATP, of actomyosin threads 
prepared from native myosin and either native actin or actin 
modified by interaction with plasma membranes 
I_~ ~-. --____ 
Threads prepared with % Original length 
__...____._-__-_.-- 
a) Myosin + native actin 57 1: 8.3 (av. 9 expt) 
b) Myosin + modified actin 58 + 10.2 (av. 12 expt) 
_-._.---~ _I_- 
Actomyosin was prepared by adding I ml of either native or 
modified G-actin (I .2 mg/mi), dissolved in 0.1 mM ATP, 
0.2 mM CaCI, and 2 mM Tris-HCl buffer (pH 8.0); to 10 ml 
myosin (0.55 mg/ml, dissolved in 0.1 M KC1 and 25 mM 
Tris-maleate buffer (pH 6.5), polymerized according to 1151. 
After sitting for 1 min at 2°C the mixture was kept at 22°C 
and after 30 mm was centrifuged at 12 000 X g for 10 min. 
The sediment was dissolved in 0.2 ml 1 M KC1 and the threads 
were prepared and treated according to [ 141. Modified actin 
was prepared by the procedure in table I 
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Fig.1. Effect of myosin subfragment-l on the native and 
modified G-a&n. (A) To a solution (1 ml) containing 
10.6 @I myosin subfragment-1,0.2 mM ATP, 0.1 mM 
CaCl,, 1 mM mercaptoethanol and 2 mM Tris-HCl buffer 
(pH 7..5), at the time indieated by the arrow, 0.12 ml of 
either 120 J& (0) native C-sctin or 120 PM (0) modified C- 
actin was added: temp. 22°C. Viscosity was measured as in 
section 2. (B) To a solution (1 ml) containing either 13 &l 
native G-actin (0) or 13 MM modified G-actin (o), 0.2 mM 
ATP, 0.1 mM C&l,, and 2 mM Tris-HCl buffer (pH 7.5); 
60 mM KC1 and 2 mM MpCl, were first added (time zero 
of the figure), followed, at the time indicated by the arrow, 
by 0.1 ml 130 ~111 myosin subfragment- dissolved in 2 mM 
Tris-HC1 buffer (pH 7.5): temp. 22°C. Relative viscosity 
was measured as in section 2. 
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Fig.2. Effect of the interaction of actin with plasma mem- 
brane. 
native G-actin to myosin subfragment-l caused the 
increase of the viscosity of the solution, the addition 
of the modified G-actin was without effect (fig.lA). 
Also without effect on the viscosity of the solu- 
tion was the mixing, in the presence of 60 mM KC1 
and 2 mM MgC12, of modified G-actin with myosin 
subfragment-l (fig.lB). Modified actin is thus kept 
in the cell as the nlonomer until ~lanlentous myosin 
is available to form a contractile unit (fig.2). This 
feature could provide a fine regulation mechanism for 
the monomer-polymer conversion of actin in the 
non-muscle cells. 
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